Thanks to the inaugural HaemSTAR National Meeting, the following sections have been updated:
Haemophilia - Extra info on newer therapies in haemophilia A, including Emicizumab
TTP - Extra detail on treatment, including Caplacizumab
Gaucher’s - Generally filled out with a few extra snippets
HaemSTAR is a UK network of haematology registrars interested in prompting and conducting audit & research in Non-Malignant haematology - We’re always looking for new people to join the team, you can read more about it here